Anu Gaggar, CFA®, FRM®, Senior Research Analyst

Anu Gaggar is a senior research analyst in Investment Management and Research at Commonwealth. With the firm since 2003, she is responsible for evaluating and selecting managers, as well as sharing research, for the international and emerging markets asset classes. She earned an MS in finance from Boston College and an MBA in finance from NMIMS in Mumbai. A CFA® charterholder, Anu also has the Financial Risk Management® (FRM®) designation and the FINRA Series 7 securities registration.

China: Value Play or Value Trap?
Given China's recent regulatory crackdown, is there a case for investing in Chinese equities?
Anu Gaggar, CFA®, FRM®
09.10.21
Will the Biogen Drug Approval Be a Boon for Biotech?
The new Alzheimer's drug from Biogen may be a boon for biotech, but investors have reasons to be wary.
Anu Gaggar, CFA®, FRM®
06.18.21
Banks Back on the Road to Recovery
As we begin to put the COVID crisis in the rearview mirror, could a new dawn be breaking for banks?
Anu Gaggar, CFA®, FRM®
05.21.21
Why Social Media-Fueled Investing Is a Call for Financial Literacy
Social platforms are driving herds of new investors to participate in the market, but the focus on hype over fundamentals points to the need to improve education to help ensure long-term financial wellness.
Anu Gaggar, CFA®, FRM®
04.28.21
5 Investing Themes for the Post-Pandemic World
By paying attention to these five investing themes for the post-pandemic world, you can help position portfolios for whatever lies ahead.
Anu Gaggar, CFA®, FRM®
04.14.21
A Sober Outlook for Emerging Market Debt
Do the potentially high yields of emerging market debt outweigh the risks for investors?
Anu Gaggar, CFA®, FRM®
03.25.21

We value your privacy

This website uses cookies and similar tools, some of which are provided by third parties, to operate and improve our website, enable social media and other features, provide a more tailored experience, and for advertising and marketing. These cookies and tools allow us and third parties to collect user data and communications, IP address and online identifiers, referring URLs and other content and browsing information, and user interactions with this site.

By clicking “Accept All Cookies,” you consent to our use of cookies and similar tools to collect and share information and acknowledge and agree to our Privacy Policy.

China: Value Play or Value Trap?

Will the Biogen Drug Approval Be a Boon for Biotech?

Banks Back on the Road to Recovery

Why Social Media-Fueled Investing Is a Call for Financial Literacy

5 Investing Themes for the Post-Pandemic World

A Sober Outlook for Emerging Market Debt